Genentech Patent Win Can't Halt Foreign Arbitration
The Federal Circuit on Friday found that Genentech Inc. cannot block a European arbitration in which it was found to have breached a cancer drug patent license with Sanofi-Aventis Deutschland GmbH,...To view the full article, register now.
Already a subscriber? Click here to view full article